[PHARMA] QoQ Cumulative Quarter Result on 31-Dec-2021 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
17-Feb-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
31-Dec-2021 [#4]
Profit Trend
QoQ- 98.62%
YoY- 526.25%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 2,647,957 1,723,276 962,174 4,815,015 4,103,297 1,970,622 793,499 123.14%
PBT 57,549 41,960 37,439 277,075 151,987 53,768 31,524 49.31%
Tax -18,402 -12,190 -8,583 -104,870 -64,947 -17,052 -8,696 64.75%
NP 39,147 29,770 28,856 172,205 87,040 36,716 22,828 43.22%
-
NP to SH 37,073 28,456 27,734 172,150 86,675 36,840 23,136 36.89%
-
Tax Rate 31.98% 29.05% 22.93% 37.85% 42.73% 31.71% 27.59% -
Total Cost 2,608,810 1,693,506 933,318 4,642,810 4,016,257 1,933,906 770,671 125.28%
-
Net Worth 411,327 406,087 413,947 450,411 391,428 357,275 355,919 10.11%
Dividend
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Div 24,889 17,029 10,479 121,768 56,292 30,100 10,468 78.04%
Div Payout % 67.14% 59.84% 37.79% 70.73% 64.95% 81.71% 45.25% -
Equity
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Net Worth 411,327 406,087 413,947 450,411 391,428 357,275 355,919 10.11%
NOSH 1,309,126 1,309,126 1,309,126 1,309,336 1,309,126 261,991 261,705 192.20%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 1.48% 1.73% 3.00% 3.58% 2.12% 1.86% 2.88% -
ROE 9.01% 7.01% 6.70% 38.22% 22.14% 10.31% 6.50% -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 202.14 131.55 73.45 367.74 313.44 150.58 303.20 -23.66%
EPS 2.83 2.17 2.12 13.15 6.62 2.82 8.84 -53.17%
DPS 1.90 1.30 0.80 9.30 4.30 2.30 4.00 -39.09%
NAPS 0.314 0.31 0.316 0.344 0.299 0.273 1.36 -62.33%
Adjusted Per Share Value based on latest NOSH - 1,309,336
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 183.73 119.57 66.76 334.09 284.71 136.73 55.06 123.14%
EPS 2.57 1.97 1.92 11.94 6.01 2.56 1.61 36.54%
DPS 1.73 1.18 0.73 8.45 3.91 2.09 0.73 77.65%
NAPS 0.2854 0.2818 0.2872 0.3125 0.2716 0.2479 0.247 10.10%
Price Multiplier on Financial Quarter End Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 -
Price 0.515 0.595 0.755 0.74 0.835 5.29 3.26 -
P/RPS 0.25 0.45 1.03 0.20 0.27 3.51 1.08 -62.26%
P/EPS 18.20 27.39 35.66 5.63 12.61 187.92 36.88 -37.52%
EY 5.50 3.65 2.80 17.77 7.93 0.53 2.71 60.22%
DY 3.69 2.18 1.06 12.57 5.15 0.43 1.23 107.86%
P/NAPS 1.64 1.92 2.39 2.15 2.79 19.38 2.40 -22.40%
Price Multiplier on Announcement Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 24/11/22 19/08/22 20/05/22 17/02/22 19/11/21 20/08/21 21/05/21 -
Price 0.55 0.595 0.72 0.76 0.845 0.925 4.03 -
P/RPS 0.27 0.45 0.98 0.21 0.27 0.61 1.33 -65.42%
P/EPS 19.43 27.39 34.01 5.78 12.76 32.86 45.59 -43.33%
EY 5.15 3.65 2.94 17.30 7.84 3.04 2.19 76.74%
DY 3.45 2.18 1.11 12.24 5.09 2.49 0.99 129.68%
P/NAPS 1.75 1.92 2.28 2.21 2.83 3.39 2.96 -29.53%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment